| Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 E Alm, EK Broberg, T Connor, EB Hodcroft, AB Komissarov, ... Eurosurveillance 25 (32), 2001410, 2020 | 256 | 2020 |
| Development of an inactivated vaccine against SARS CoV-2 STI Pavel, H Yetiskin, MA Uygut, AF Aslan, G Aydın, Ö İnan, B Kaplan, ... Vaccines 9 (11), 1266, 2021 | 43 | 2021 |
| Francisella is sensitive to insect antimicrobial peptides M Vonkavaara, STI Pavel, K Hölzl, R Nordfelth, A Sjöstedt, S Stöven Journal of Innate Immunity 5 (1), 50-59, 2013 | 38 | 2013 |
| Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in Nicotiana benthamiana Plant as a Vaccine Candidate against … T Mamedov, D Yuksel, M Ilgın, I Gürbüzaslan, B Gulec, G Mammadova, ... Vaccines 9 (11), 1337, 2021 | 35 | 2021 |
| Plant-produced glycosylated and in vivo deglycosylated receptor binding domain proteins of SARS-CoV-2 induce potent neutralizing responses in mice T Mamedov, D Yuksel, M Ilgın, I Gurbuzaslan, B Gulec, H Yetiskin, ... Viruses 13 (8), 1595, 2021 | 28 | 2021 |
| Isolation and characterization of severe acute respiratory syndrome coronavirus 2 in Turkey STI Pavel, H Yetiskin, G Aydin, C Holyavkin, MA Uygut, ZB Dursun, I Celik, ... PLoS One 15 (9), e0238614, 2020 | 22 | 2020 |
| Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse … STI Pavel, H Yetiskin, A Kalkan, A Ozdarendeli PLoS Neglected Tropical Diseases 14 (11), e0008834, 2020 | 17 | 2020 |
| Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled … A Ozdarendeli, Z Sezer, STI Pavel, A Inal, H Yetiskin, B Kaplan, MA Uygut, ... Vaccine 41 (2), 380-390, 2023 | 16 | 2023 |
| Preclinical studies on convalescent human immune plasma-derived exosome: Omics and antiviral properties to SARS-CoV-2 NP Taşlı, ZB Gönen, OK Kırbaş, NS Gökdemir, BT Bozkurt, B Bayrakcı, ... Frontiers in Immunology 13, 824378, 2022 | 10 | 2022 |
| Plant-produced RBD and cocktail-based vaccine candidates are highly effective against SARS-CoV-2, independently of its emerging variants T Mamedov, D Yuksel, I Gürbüzaslan, M Ilgın, B Gulec, G Mammadova, ... Frontiers in Plant Science 14 (14-2023), 2023.1202570, 2023 | 5 | 2023 |
| Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: Interim results from randomised, double-blind, placebo-controlled … A ÖZDARENDELİ, Z SEZER, S PAVEL, A İNAL, H YETİŞKİN, B KAPLAN, ... Vaccine 41 (2), 2023 | 1 | 2023 |
| Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up Z Sezer, STI Pavel, A Inal, H Yetiskin, B Kaplan, MA Uygut, AF Aslan, ... Vaccines 12 (2), 140, 2024 | | 2024 |
| SARS-CoV-2 spike protein S1 subunit induces potent neutralizing responses in mice and is effective against Delta and Omicron variants T Mamedov, D Yuksel, I Gurbuzaslan, B Gulec, G Mammadova, ... Frontiers in Plant Science 14, 1290042, 2023 | | 2023 |
